Pemirolast

Chemical formula: C₁₀H₈N₆O  Molecular mass: 228.21 g/mol  PubChem compound: 57697

Active ingredient description

Pemirolast potassium is a mast cell stabilizer that inhibits the in vivo Type I immediate hypersensitivity reaction. In vitro and in vivo studies have demonstrated that pernirolast inhibits the antigen-induced release of inflanunatory mediators (e.g., histamine, leukotriene C4, D4, E4) from human mast cells. In addition, pemirolast inhibits the chemotaxis of eosinophils into ocular tissue and blocks the release of mediators from human easinophils. Although the precise mechanism of action is unknown, the drug has been reported to prevent calcium influx into mast cells upon antigen stimulation.

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
ALAMAST Ophthalmic solution Web Search MPI, US: SPL/Old

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 69372-19-6
DrugBank Drug: DB00885
KEGG Drug: D01088
PubChem Compound: 57697
RxNorm Ingredient: 19551
SNOMED-CT Concept: 417508009
Pemirolast (substance)
UNII Identifier: 2C09NV773M
PEMIROLAST

Medicines

Pemirolast is an active ingredient of these brands:

Hong Kong (HK)

Japan (JP)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.